Lista de obras - Fernando Magro - Dominio Público Uruguay

"A book should not be judged by its cover": two cases of intestinal adenocarcinoma as the first manifestation of Crohn's disease

scientific article published on 26 September 2015

Advanced imaging techniques for small bowel Crohn's disease: what does the future hold?

artículo científico publicado en 2018

Amine neurotransmitters, inflammation and epithelial sodium transport

artículo científico publicado en 2015

Aminosalicylates and COVID-19: Facts or Coincidences?

scientific article published on 15 June 2020

Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study

artículo científico publicado en 2016

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.

artículo científico publicado en 2013

Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg?

artículo científico publicado en 2015

Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature

artículo científico publicado en 2012

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

artículo científico publicado en 2018

Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling

artículo científico publicado en 2015

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease

artículo científico publicado en 2017

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases

artículo científico publicado en 2015

C-reactive protein in Crohn's disease: how informative is it?

artículo científico publicado en 2014

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a

artículo científico publicado en 2010

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events ⬇️

artículo científico publicado el 4 de enero de 2010

Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis

artículo científico publicado en 2013

Clinical trials in ulcerative colitis: a historical perspective

artículo científico

Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum

artículo científico publicado en 2005

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

scientific article published on 01 April 2019

Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe

artículo científico publicado en 2011

Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study

artículo científico publicado en 2015

Crohn's disease in a southern European country: Montreal classification and clinical activity

artículo científico publicado en 2009

Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience

artículo científico publicado en 2013

Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptake.

artículo científico publicado en 2004

Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review

artículo científico publicado en 2013

Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment.

artículo científico publicado en 2006

Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification

artículo científico publicado en 2010

ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology

artículo científico publicado en 2020

Earlier need of infliximab intensification in ulcerative colitis than in Crohn's disease

scientific article published on 29 March 2014

Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis?

artículo científico publicado en 2015

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

artículo científico publicado en 2013

Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors’ reply

artículo científico publicado en 2018

Editorial: ulcerative colitis submucosal fibrosis and inflammation: more than just strictures

artículo científico publicado en 2018

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

artículo científico publicado en 2013

Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.

artículo científico publicado en 2013

Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach.

artículo científico publicado en 2010

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases

artículo científico publicado en 2014

European consensus on the histopathology of inflammatory bowel disease.

artículo científico publicado en 2013

European evidence based consensus on surgery for ulcerative colitis

artículo científico publicado en 2015

Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

artículo científico publicado en 2013

Gingival Hyperplasia as a First Manifestation of Crohn's Disease

artículo científico publicado en 2005

Gut bacterial microbiome composition and statin intake-A systematic review

artículo científico publicado en 2020

Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study

artículo científico publicado en 2014

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.

artículo científico publicado en 2014

High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment

artículo científico publicado en 2013

High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease

artículo científico publicado en 2003

How to manage pouchitis in ulcerative colitis?

artículo científico publicado en 2011

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

artículo científico publicado en 2013

Imaging techniques in IBD and their role in follow-up and surveillance

artículo científico publicado en 2014

Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients

scientific article published on 01 July 1996

Immunisations in Crohn's disease: who? why? what? when?

artículo científico publicado en 2014

Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

artículo científico publicado en 2002

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.

artículo científico publicado en 2014

Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment

artículo científico publicado en 2015

Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce

artículo científico publicado en 2020

Infliximab dose intensification by shortening infusion intervals

artículo científico publicado en 2008

Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis

artículo científico publicado en 2013

Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection

article

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

article

Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.

artículo científico publicado en 2014

Interferon-gamma-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells

artículo científico publicado en 2005

Intestinal 5-Hydroxytryptamine and Mast Cell Infiltration in Rat Experimental Colitis

artículo científico publicado en 2006

Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation

artículo científico publicado en 2004

Ionizing radiation exposure is still increasing in Crohn's disease: Who should be blamed?

artículo científico publicado en 2015

Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression

artículo científico publicado en 2014

Is tofacitinib a game-changing drug for ulcerative colitis?

scientific article published on 18 June 2020

Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature

artículo científico

Listeria monocytogenes bacteremia and CMV colitis in a patient with Ulcerative Colitis

artículo científico publicado en 2013

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report

artículo científico publicado en 2011

Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease

artículo científico publicado en 2006

Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection.

artículo científico publicado en 2011

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies

scientific article published on December 2010

Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.

artículo científico

Metastatic cutaneous Crohn's disease of the face: a case report and review of the literature.

artículo científico publicado en 2011

Mimicry between intestinal Behçet's disease and inflammatory bowel disease

scientific article published on 02 January 2014

Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

artículo científico publicado en 2015

Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature

artículo científico

Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.

artículo científico

Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II).

artículo científico publicado en 2013

Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease

artículo científico publicado en 2015

Reactive Hepatitis in a Patient with Crohnʼs Disease Successfully Treated With Infliximab: Does Tumor Necrosis Factor Alpha Play a Role in Reactive Hepatitis?

scientific article published on 01 January 2005

Refractory monogenic Crohn's disease due to X-linked inhibitor of apoptosis deficiency.

artículo científico publicado en 2015

Regional intestinal adaptations in Na+,K+-ATPase in experimental colitis and the contrasting effects of interferon-gamma

artículo científico publicado en 2005

Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study

artículo científico publicado en 2020

Reintroduction of Anti-TNFα Therapy After (or even During) Anti-TNFα-associated Tuberculosis in Immune-mediated Diseases

artículo científico publicado en 2015

Response to Irwin et al

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

artículo científico

Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease

artículo científico publicado en 2014

Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts.

artículo científico publicado en 2011

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

artículo científico publicado en 2012

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

artículo científico

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)

artículo científico publicado en 2014

Severe gram positive bacterial infection in an ulcerative colitis patient treated with Infliximab

artículo científico publicado en 2009

Short- and long-term regulation of intestinal Na+/H+ exchange activity associated with TLR2 receptor activation is independent of nuclear factor-κB signaling

artículo científico publicado en 2013

Short- and long-term regulation of intestinal Na+/H+ exchange by Toll-like receptors TLR4 and TLR5.

artículo científico publicado en 2015

Short-term effect on intestinal epithelial Na+/H+ exchanger by Giα1,2-coupled 5-HT1A and Gq/11-coupled 5-HT2 receptors

artículo científico publicado en 2007

Signaling of short- and long-term regulation of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma

artículo científico publicado en 2005

Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab

artículo científico publicado en 2019

Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

artículo científico publicado en 2004

Stool Isolation of Nocardia nova in Two Immunomodulated Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2016

Systematic review on drug and diet-induced endoscopic remission in Crohn's disease.

artículo científico publicado en 2009

The histopathological approach to inflammatory bowel disease: a practice guide

scientific article published on 01 February 2014

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis

artículo científico publicado en 2023

The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis

artículo científico publicado en 2017

The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study

scientific article published on 26 July 2020

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort

artículo científico publicado en 2015

Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.

artículo científico publicado en 2013

Ulcerative colitis in a Southern European country: a national perspective

artículo científico publicado en 2010

Ulcerative colitis in northern Portugal and Galicia in Spain

artículo científico publicado en 2010

Unusual Presentation of Tuberculosis After Infliximab Therapy

artículo científico publicado en 2005

Venous thrombosis and prothrombotic factors in inflammatory bowel disease

artículo científico publicado en 2014

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale

scientific article published on 21 August 2019

[Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease].

artículo científico publicado en 2016

Lista de obras de Fernando Magro

"A book should not be judged by its cover": two cases of intestinal adenocarcinoma as the first manifestation of Crohn's disease

Advanced imaging techniques for small bowel Crohn's disease: what does the future hold?

Amine neurotransmitters, inflammation and epithelial sodium transport

Aminosalicylates and COVID-19: Facts or Coincidences?

Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.

Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg?

Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease

Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases

C-reactive protein in Crohn's disease: how informative is it?

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a

Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events ⬇️

Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis

Clinical trials in ulcerative colitis: a historical perspective

Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe

Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study

Crohn's disease in a southern European country: Montreal classification and clinical activity

Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience

Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptake.

Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review

Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment.

Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification

ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology

Earlier need of infliximab intensification in ulcerative colitis than in Crohn's disease

Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis?

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors’ reply

Editorial: ulcerative colitis submucosal fibrosis and inflammation: more than just strictures

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.

Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach.

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases

European consensus on the histopathology of inflammatory bowel disease.

European evidence based consensus on surgery for ulcerative colitis

Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

Gingival Hyperplasia as a First Manifestation of Crohn's Disease

Gut bacterial microbiome composition and statin intake-A systematic review

Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.

High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment

High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease

How to manage pouchitis in ulcerative colitis?

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

Imaging techniques in IBD and their role in follow-up and surveillance

Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients

Immunisations in Crohn's disease: who? why? what? when?

Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.

Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment

Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce

Infliximab dose intensification by shortening infusion intervals

Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis

Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis

Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.

Interferon-gamma-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells

Intestinal 5-Hydroxytryptamine and Mast Cell Infiltration in Rat Experimental Colitis

Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation

Ionizing radiation exposure is still increasing in Crohn's disease: Who should be blamed?

Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression

Is tofacitinib a game-changing drug for ulcerative colitis?

Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature

Listeria monocytogenes bacteremia and CMV colitis in a patient with Ulcerative Colitis

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report

Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease

Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies

Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.

Metastatic cutaneous Crohn's disease of the face: a case report and review of the literature.

Mimicry between intestinal Behçet's disease and inflammatory bowel disease

Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature

Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.

Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II).